Suppl. Fig. 2 . TEM images of Pd-Exo A549 stained with Phosphotungstic acid.
UV-VIS Spectroscopy
Optical properties of Pd-Exo A549 were studied using a UV-VIS spectroscopy (Jasco V670). As shown in Suppl. Fig. 3 , a surface plasmon resonance peak was observed in the near infrared range, which corresponds to the expected absorbance peak of ultrathin Pd nanosheets. This result is in agreement with the literature. 4
Suppl. Fig. 3 . UV-VIS absorption spectrum of Pd-Exo A549 showing a maximum surface plasmon resonance peak at approx. 900 nm.
Inductively coupled plasma mass spectrometry (ICP-MS)
The content of Pd loaded inside Pd-Exo A549 was quantified by inductively coupled plasma mass spectrometry (ICP-MS) and normalized by total protein amount in the exosomes. The Pd-Exo A549 total protein was determined by BCA assay as described in Finally, a spike test was carried out adding a solution with a concentration of 1.0791 ng/mL. An average recovery of 86.7% was found for the different Pd isotopes. 
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Suppl. Fig. 4 . Energy-dispersive X-ray spectroscopy analysis (EDS) of Pd-Exo A549 . EDS analysis was carried out in the marked area of the STEM-HAADF image.
X-Ray Photoelectron Spectroscopy
The elemental composition of the Pd-Exo A549 and the chemical environmental of Pd atoms were evaluated using X-Ray photoelectron spectroscopy (XPS) by using an Axis Supra (Kratos Analytical, UK). A monochromatic Al Kα X-ray radiation (hv= 1486.6 eV) was employed as excitation source at 15 kV and 15 mA. The Pd-Exo A549 were previously deposited onto a cover slip and left to dry completely. The peaks analysis was carried out by the CasaXPS software (Casa Software Ltd, UK).
The core level Pd 3d3/2 centered at 335.2 eV was attributed to the presence of Pd 0 in agreement with the previous literature. 5 Suppl. Fig 5. Figure 1f were taken.
Stability study
In order to evaluate the stability of the Pd-loaded exosomes, the particle size of Exo A549
and Pd-Exo A549 were analyzed at different time points using a Nanosight NS50 (Mavern Instruments Ltd, Malvern, UK). Moreover, the zeta potential of Exo A549 , CO treated Exo A549 and Pd-Exo A549 was also measured by dynamic light scattering (DLS) at pH=7 in a Brookhaven 90 Plus equipment using the ZetaPals software. Both the particle size and the zeta potential were evaluated at 3 time points (0, 24 and 72 h) after synthesis. Suppl. Fig. 11 . A549 and U87 cell viability study after treatment with Pd-Exo A549 . Cell viability was measured at day 5 using PrestoBlue® reagent. Error bars: ± SEM, n = 3. We have also employed confocal microscopy to monitor the association of Pd-Exo A549 with the endo-lysosomal pathway (Spectral Confocal Microscope Leica TCA SP2 and ZEISS LSM880 Confocal Laser Scanning Microscope). To this end, A549 cells were seeded onto a cover slip and were incubated with Pd-Exo A549 for 6 h. Then, they were fixed with 4 % PFA as previously mentioned. Endosomes and exosomes were labeled with a specific CD63-Alexa-488 antibody (Thermo Fisher Scientific, USA), the nuclei were stained with Draq-5 (gray) and the Pd-Exo A549 were directly observed by reflection of the incident light in the microscope at 488/490 nm ex/em. For lysosomes labeling, cells were firstly marked with LysoTracker Green (Invitrogen, USA) following manufacter instructions. Then, cells were fixed with 4 %PFA. Z-stack orthogonal projections from confocal laser-scanning microscopy study were employed to determine the presence of Pd within the endo-lysosomal pathway.
Confocal study of Pd-Exo A549 cell internalization
Suppl. Fig. 14. Confocal study of the intracellular location of Pd-Exo A549 after incubation for 6 h with A549 cells. After treatment, cells were fixed and labelled with Draq5 (grey) and either a specific CD63-Alexa488 antibody or lysotracker (blue). Pd-Exo A549 were directly observed by reflection of the incident light (red). The right images show the amplified and z-stacks sections. Control= untreated cells. Suppl. Fig. 19 . Pd-Exo mediated conversion of non-fluorescent 1 into highly redfluorescent resorufin 2 under biocompatible conditions (37 °C, PBS, pH 7.4, isotonicity). Conversion efficiency after 24 h or 48 h incubation of 1 (100 µM) with Pd-Exo A549 or Pd-Exo U87 (0.4 µg / 100 µL). Conversion values (%) were calculated from fluorescence intensity measurements at λex/em= 540/590 nm using the fluorescence intensity of 2 (100 µM) as 100 %. Negative controls: 1 (100 µM), Pd-Exo A549 or Pd-Exo U87 (0.4 µg / 100 µL). Error bars: ±SD, n=3.
1.4.8. Cell viability and intracellular prodrug activation study in RAW cells RAW cells were plated as indicated in above. For cell viability assay, each well was then replaced with fresh media, containing compounds 3 and 4 (0.003-100 µM).
Untreated cells were incubated with DMSO (0.1 % v/v).
For intracellular prodrug activation assay, the corresponding wells were then replaced with a suspension of Pd-Exo A549 or Pd-Exo U87 in culture media depleted of exosomes (at 0.4 µg / 100 µL). After 6 h of incubation, these wells were washed with PBS buffer to remove extracellular vesicles and treated with fresh media containing either DMSO (0.1% v/v) or 4 (0.2 µM). Cells treated with 3 and 4 at 0.2 µM were used as positive and negative controls, respectively. After 5 d of incubation, cell viability was determined as described above. All conditions were normalized to the untreated cells (100 %) and curves fitted using GraphPad Prism using a sigmoidal variable slope curve.
Experiments were performed in triplicates.
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Suppl. Fig. 20 . (A) RAW 264.7 dose-response curves after 5 d treatment with 3 and 4. Curves fit: sigmoidal variable slope curves. Error bars: ± SEM, n = 3. (B) Pd-Exo-mediated uncaging of 4 inside RAW 264.7 cells. Cells were incubated for 6 h with 0.4 µg / 100 µL of either Pd-Exo A549 or Pd-Exo U87 . Cells were thoroughly washed to eliminate extracellular vesicles followed by addition of prodrug 4 (0.2 µM). Controls: Pd-Exo A549 / Pd-Exo U87 only (-ve control, grey); prodrug 4 only (-ve control, purple); 3 (+ve control, green). Cell viability was measured at day 5 using PrestoBlue. Error bars: ± SEM, n = 3. ***P < 0.001 (ANOVA).
